Jefferies Cuts Price Target on Marine Bio (MBII) Following a Light 1Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Piper Jaffray Cuts Price Target on Marine Bio (MBII) Following 1Q Report
May 13, 2016 7:58 AM EDTPiper Jaffray maintained an Overweight rating on Marrone Bio Innovations (NASDAQ: MBII), and cut the price target to $1.00 (from $2.00), following the company's 1Q earnings report. Marrone again beat Piper's top line expectations in the March ending quarter as sales growth in the specialty crop market continues to be stronger than expected, more than... More
